Skip to main content
Log in

Lokal fortgeschrittenes Rektumkarzinom

Was ist der klinische Benefit bei der präoperativen Radiochemotherapie mit 5-Fluorouracil/Leucovorin?

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Gerard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625

    Article  PubMed  Google Scholar 

  2. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123

    Article  PubMed  CAS  Google Scholar 

  3. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative radiochemotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.J. Feldmann.

Additional information

Eine gemeinsame Analyse zweier großer randomisierter Studien (EORTC 22921 und FFCD 9203).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldmann, H. Lokal fortgeschrittenes Rektumkarzinom. Onkologe 19, 147–148 (2013). https://doi.org/10.1007/s00761-012-2400-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-012-2400-1

Navigation